Barrington Research Cuts Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Barrington Research reduced their FY2026 earnings per share (EPS) estimates for Henry Schein in a report issued on Thursday, January 30th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings of $5.25 per share for the year, down from their prior forecast of $5.80. Barrington Research currently has a “Outperform” rating and a $90.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same quarter in the prior year, the business earned $1.32 earnings per share. The company’s revenue was up .4% on a year-over-year basis.

Several other equities research analysts also recently issued reports on the stock. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Evercore ISI boosted their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Seven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $80.10.

Henry Schein Stock Down 0.0 %

Henry Schein stock opened at $80.00 on Monday. The firm has a market cap of $9.97 billion, a price-to-earnings ratio of 32.92, a P/E/G ratio of 2.20 and a beta of 0.89. The firm has a fifty day moving average price of $73.41 and a two-hundred day moving average price of $71.46. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Institutional Investors Weigh In On Henry Schein

Several large investors have recently made changes to their positions in the company. Clarkston Capital Partners LLC boosted its position in Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after buying an additional 71,560 shares in the last quarter. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Henry Schein during the 3rd quarter worth approximately $515,000. Olstein Capital Management L.P. increased its holdings in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after purchasing an additional 16,000 shares in the last quarter. Finally, Thrivent Financial for Lutherans raised its position in Henry Schein by 1,848.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock valued at $7,685,000 after purchasing an additional 100,006 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.14% of the stock is owned by insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.